ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance [Yahoo! Finance]
Elite Pharmaceuticals, Inc. (ELTP)
NASDAQ:AMEX Investor Relations:
ir.elitepharma.com
Company Research
Source: Yahoo! Finance
This compares with the S&P 500 Index's 2.2% loss over the same period. Over the past month, Elite stock plunged 4.9%, while the S&P 500 slipped 2%. ELTP's Earnings and Revenue Performance In the second quarter of fiscal 2026, Elite Pharmaceuticals posted revenues of $36.3 million, up 92.4% year over year from $18.9 million, driven largely by the launch and rapid expansion of its lisdexamfetamine (generic Vyvanse) product line. Income from operations surged 135.7% year over year to $8.2 million from $3.5 million, reflecting increased scale and a stronger product mix. ELTP's gross profit of $14.1 million rose 71.7% year over year from $8.2 million, although margins tightened sequentially due to price competition in the generic Vyvanse market and one-time wholesaler stocking fees. Elite Pharmaceuticals posted net income of $13.7 million for the quarter, translating to earnings of $0.01 per share, against a net loss of $11 million, or 1 cent per share in the year-ago period. R&D spe
Show less
Read more
Impact Snapshot
Event Time:
ELTP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELTP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELTP alerts
High impacting Elite Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ELTP
News
- Elite Pharmaceuticals, Inc. (ELTP) Q2 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Elite Pharmaceuticals Inc (ELTP) Q2 2026 Earnings Call Highlights: Surging Revenues and ... [Yahoo! Finance]Yahoo! Finance
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information [Yahoo! Finance]Yahoo! Finance
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 [Yahoo! Finance]Yahoo! Finance
ELTP
Sec Filings
- 11/14/25 - Form 8-K
- 11/14/25 - Form 10-Q
- 11/12/25 - Form 8-K/A
- ELTP's page on the SEC website